Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
β Scribed by H. G. Kopp; S. Yildirim; K. C. Weisel; L. Kanz; W. Vogel
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 284 KB
- Volume
- 135
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Highβdose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard therapy for newly diagnosed multiple myeloma. Combinations of recently proposed prognostic factors such as cytogenetics and international scoring system (ISS) may be useful to predict prognosis
## Neophosphotransferase MMuL V promoter Retroviral transfer PA-317 Peripheral blood leukapheresis preparations Gene marking of peripheral blood progenitor cells for high dose therapy of multiple myeloma None as of yet 30 One or two per month 2 years (1995)(1996) Abbreviations CDR Complementarity-